Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Maury

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1994
Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptidesC P Maury, E L Nurmiaho-Lassila, H Rossi
Clinical Science (London, England : 1979)|April 1, 1983
alpha 1-Antitrypsin and reactive systemic amyloidosisC P Maury, A M Teppo, B Fröseth, et al.
FEBS Letters|November 29, 1993
Variant plasma gelsolin responsible for familial amyloidosis (Finnish type) has defective actin severing activityA G Weeds, J Gooch, P McLaughlin, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 1, 1987
Antibodies to 90 kilodalton glycoprotein in childhood and adolescent celiac disease: relationship to reticulin antibodiesA M Teppo, M Mäki, O Hällström, et al.
Diabetes Research (Edinburgh, Scotland)|August 1, 1988
No sign of amyloidosis in pump-treated diabeticsH Regal, V A Koivisto, C P Maury, et al.
Transplantation Proceedings|October 1, 1987
Monitoring of high-density lipoprotein-associated amyloid A protein after liver transplantationC P Maury, K Höckerstedt, I Lautenschlager, et al.
The American Journal of Medicine|September 1, 1988
Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndromeJ Lähdevirta, C P Maury, A M Teppo, et al.
FEBS Letters|December 10, 1990
Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin geneC P Maury, J Kere, R Tolvanen, et al.
British Medical Journal (Clinical Research Ed.)|February 4, 1984
Measurement of serum amyloid A protein concentrations as test of renal allograft rejection in patients with initially non-functioning graftsC P Maury, A M Teppo, J Ahonen, et al.
Scandinavian Journal of Rheumatology|January 1, 1985
Human high-density lipoprotein associated amyloid A protein. Structural characteristics, relation to apo A-I and A-II concentrations, and plasma clearance kinetics in the ratC Ehnholm, A M Teppo, J J Ohisalo, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1994
Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptidesC P Maury, E L Nurmiaho-Lassila, H Rossi
Clinical Science (London, England : 1979)|April 1, 1983
alpha 1-Antitrypsin and reactive systemic amyloidosisC P Maury, A M Teppo, B Fröseth, et al.
FEBS Letters|November 29, 1993
Variant plasma gelsolin responsible for familial amyloidosis (Finnish type) has defective actin severing activityA G Weeds, J Gooch, P McLaughlin, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 1, 1987
Antibodies to 90 kilodalton glycoprotein in childhood and adolescent celiac disease: relationship to reticulin antibodiesA M Teppo, M Mäki, O Hällström, et al.
Diabetes Research (Edinburgh, Scotland)|August 1, 1988
No sign of amyloidosis in pump-treated diabeticsH Regal, V A Koivisto, C P Maury, et al.
Transplantation Proceedings|October 1, 1987
Monitoring of high-density lipoprotein-associated amyloid A protein after liver transplantationC P Maury, K Höckerstedt, I Lautenschlager, et al.
The American Journal of Medicine|September 1, 1988
Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndromeJ Lähdevirta, C P Maury, A M Teppo, et al.
FEBS Letters|December 10, 1990
Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin geneC P Maury, J Kere, R Tolvanen, et al.
British Medical Journal (Clinical Research Ed.)|February 4, 1984
Measurement of serum amyloid A protein concentrations as test of renal allograft rejection in patients with initially non-functioning graftsC P Maury, A M Teppo, J Ahonen, et al.
Scandinavian Journal of Rheumatology|January 1, 1985
Human high-density lipoprotein associated amyloid A protein. Structural characteristics, relation to apo A-I and A-II concentrations, and plasma clearance kinetics in the ratC Ehnholm, A M Teppo, J J Ohisalo, et al.
Pageof 12